Biostax Corp.

BTAX · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$2,363-$3,536$1,589
Dep. & Amort.$54$0$1
Deferred Tax$0$0$0
Stock-Based Comp.$0$0$0
Change in WC$848$702$1,012
Other Non-Cash$1,052$2,252-$2,793
Operating Cash Flow-$408-$582-$192
Investing Activities
PP&E Inv.$0-$500$0
Net Acquisitions$0$0$0
Inv. Purchases$0$0$0
Inv. Sales/Matur.$0$0$0
Other Inv. Act.$0$0$0
Investing Cash Flow$0-$500$0
Financing Activities
Debt Repay.$138$315$197
Stock Issued$0$0$0
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.$150$423$0
Financing Cash Flow$287$738$197
Forex Effect$0$0$0
Net Chg. in Cash-$121-$343$5
Supplemental Information
Beg. Cash$150$494$5
End Cash$30$150$10
Free Cash Flow-$408-$1,082-$192